Owner Genentech, Inc.

Inventors Wood, William I; Kuo, Sophia S; Hillan, Kenneth J; Goddard, Audrey; Williams, P Mickey; Gerber, Hanspeter; Paoni, Nicholas F; Godowski, Paul J; Ferrara, Napoleone; Gurney, Austin L; Smith, Victoria; Ashkenazi, Avi J; Baker, Kevin P; Klein, Robert D; Watanabe, Colin K

Agent Griffith Hack

Pub. Number AU-B-2003259607

Parent 17482

Filing date 31 October 2003

Wipo publication date 27 November 2003

Acceptance publication date 3 November 2005

A61K 038/17 Medicinal preparations containing peptides - from animals

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 019/00 Hybrid peptides

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 014/47 Peptides having more than 20 amino acids

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

C12N 015/867 Mutation or genetic engineering - Retroviral vectors